{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T19:16:26Z","timestamp":1777749386026,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Provincial and Municipal Joint Fund of the Natural Science Foundation of Hunan Province, China","award":["2020JJ6109"],"award-info":[{"award-number":["2020JJ6109"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03192-w","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T15:23:58Z","timestamp":1752679438000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Small nuclear ribonucleoprotein polypeptide B2 regulated by SNHG4\/miR-204-5p axis inhibits ferroptosis to aggravate the progression of hepatocellular carcinoma"],"prefix":"10.1007","volume":"16","author":[{"given":"Jiaxing","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingshu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenqin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanjuan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bokang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"issue":"3","key":"3192_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"Cancer J Clin"},{"key":"3192_CR2","doi-asserted-by":"crossref","unstructured":"Rumgay H, Ferlay J, DE Martel C et al. Global, regional and national burden of primary liver cancer by subtype [J]. Eur J Cancer (Oxf Engl 1990). 2022;161: 108\u201318.","DOI":"10.1016\/j.ejca.2021.11.023"},{"issue":"4","key":"3192_CR3","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1001\/jamasurg.2022.7989","volume":"158","author":"ZJ Brown","year":"2023","unstructured":"Brown ZJ, Tsilimigras DI, Ruff SM, et al. Management of hepatocellular carcinoma: A review [J]. JAMA Surg. 2023;158(4):410\u201320.","journal-title":"JAMA Surg"},{"issue":"3","key":"3192_CR4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jhep.2020.09.026","volume":"74","author":"TH Kim","year":"2021","unstructured":"Kim TH, Koh YH, Kim BH, et al. Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial [J]. J Hepatol. 2021;74(3):603\u201312.","journal-title":"J Hepatol"},{"issue":"1","key":"3192_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1470-2045(21)00604-5","volume":"23","author":"T Yau","year":"2022","unstructured":"Yau T, Park JW, Finn RS, et al. Nivolumab versus Sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial [J]. Lancet Oncol. 2022;23(1):77\u201390.","journal-title":"Lancet Oncol"},{"key":"3192_CR6","doi-asserted-by":"crossref","unstructured":"Barteselli C, Mazza S, Ravetta V et al. Ultrasound patterns of hepatocellular carcinoma and their prognostic impact: a retrospective study [J]. Cancers. 2023;15(22).","DOI":"10.3390\/cancers15225396"},{"issue":"6","key":"3192_CR7","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1002\/hep.32447","volume":"75","author":"F Foerster","year":"2022","unstructured":"Foerster F, Gairing SJ, Ilyas SI, et al. Emerging immunotherapy for HCC: a guide for hepatologists [J]. Hepatol (Baltim Md). 2022;75(6):1604\u201326.","journal-title":"Hepatol (Baltim Md)"},{"issue":"2","key":"3192_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, et al. Ferroptosis: A regulated cell death Nexus linking metabolism, redox biology, and disease [J]. Cell. 2017;171(2):273\u201385.","journal-title":"Cell"},{"issue":"1","key":"3192_CR9","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41392-023-01606-1","volume":"8","author":"S Sun","year":"2023","unstructured":"Sun S, Shen J, Jiang J, et al. Targeting ferroptosis opens new avenues for the development of novel therapeutics [J]. Signal Transduct Target Therapy. 2023;8(1):372.","journal-title":"Signal Transduct Target Therapy"},{"key":"3192_CR10","first-page":"180","volume":"504","author":"L Sousa","year":"2020","unstructured":"Sousa L, Oliveira MM, Pess\u00f4a MTC, et al. Iron overload: effects on cellular biochemistry [J]. Int J Clin Chem. 2020;504:180\u20139. Clinica chimica acta.","journal-title":"Int J Clin Chem"},{"issue":"1\u20132","key":"3192_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, Sriramaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by GPX4 [J]. Cell. 2014;156(1\u20132):317\u201331.","journal-title":"Cell"},{"key":"3192_CR12","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.actbio.2023.07.042","volume":"169","author":"J Yu","year":"2023","unstructured":"Yu J, Zhang Y, LI L, et al. Coordination-driven FBXW7 DNAzyme-Fe nanoassembly enables a binary switch of breast cancer cell cycle checkpoint responses for enhanced ferroptosis-radiotherapy [J]. Acta Biomater. 2023;169:434\u201350.","journal-title":"Acta Biomater"},{"key":"3192_CR13","doi-asserted-by":"crossref","unstructured":"Zhang W, Dai J, Hou G et al. SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation [J]. Mol Cell; 2023.","DOI":"10.1016\/j.molcel.2023.10.042"},{"issue":"36","key":"3192_CR14","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1038\/s41388-023-02744-0","volume":"42","author":"Z Wang","year":"2023","unstructured":"Wang Z, Ouyang L, Liu N, et al. The DUBA-SLC7A11-c-Myc axis is critical for stemness and ferroptosis [J]. Oncogene. 2023;42(36):2688\u2013700.","journal-title":"Oncogene"},{"issue":"21","key":"3192_CR15","doi-asserted-by":"publisher","first-page":"6348","DOI":"10.1093\/emboj\/17.21.6348","volume":"17","author":"F Caspary","year":"1998","unstructured":"Caspary F, S\u00e9raphin B. The yeast U2A\u2019\/U2B complex is required for pre-spliceosome formation [J]. EMBO J. 1998;17(21):6348\u201358.","journal-title":"EMBO J"},{"issue":"8","key":"3192_CR16","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2174\/1568009623666230316152713","volume":"23","author":"M Deng","year":"2023","unstructured":"Deng M, Yuan H, Peng H, et al. LINC00461 knockdown enhances the effect of Ixazomib in multiple myeloma cells [J]. Curr Cancer Drug Targets. 2023;23(8):643\u201352.","journal-title":"Curr Cancer Drug Targets"},{"key":"3192_CR17","doi-asserted-by":"publisher","first-page":"1536473","DOI":"10.3389\/fonc.2025.1536473","volume":"15","author":"J Bao","year":"2025","unstructured":"Bao J, Tian X, Pan Y, et al. SNRPB2: a prognostic biomarker and oncogenic driver in esophageal cancer via \u03b2-catenin\/c-Myc signaling [J]. Front Oncol. 2025;15:1536473.","journal-title":"Front Oncol"},{"issue":"7","key":"3192_CR18","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/cbf.3510","volume":"38","author":"Y Luo","year":"2020","unstructured":"Luo Y, Lin J, Zhang Y, et al. LncRNA PCAT6 predicts poor prognosis in hepatocellular carcinoma and promotes proliferation through the regulation of cell cycle arrest and apoptosis [J]. Cell Biochem Funct. 2020;38(7):895\u2013904.","journal-title":"Cell Biochem Funct"},{"key":"3192_CR19","doi-asserted-by":"crossref","unstructured":"Nemeth K, Bayraktar R, Ferracin M, et al. Non-coding RNAs in disease: from mechanisms to therapeutics [J]. Nat Rev Genet; 2023.","DOI":"10.1038\/s41576-023-00662-1"},{"issue":"21","key":"3192_CR20","doi-asserted-by":"publisher","first-page":"e70150","DOI":"10.1111\/jcmm.70150","volume":"28","author":"M Hosseini","year":"2024","unstructured":"Hosseini M, Mokhtari MJ. Up-regulation of HOXA-AS2 and MEG3 long non-coding RNAs acts as a potential peripheral biomarker for bipolar disorder [J]. J Cell Mol Med. 2024;28(21):e70150.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"3192_CR21","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1007\/s11033-024-09818-6","volume":"51","author":"F Keshavarz","year":"2024","unstructured":"Keshavarz F, Mokhtari MJ, Poursadeghfard M. Increased level of GATA3-AS1 long non-coding RNA is correlated with the upregulation of GATA3 and IL-4 genes in multiple sclerosis patients [J]. Mol Biol Rep. 2024;51(1):874.","journal-title":"Mol Biol Rep"},{"key":"3192_CR22","doi-asserted-by":"crossref","unstructured":"Amiri M, Mokhtari MJ, Bayat M et al. Expression and diagnostic values of MIAT, H19, and NRON long non-coding RNAs in multiple sclerosis patients [J]. Egypt J Med Hum Genet. 2022;23(1).","DOI":"10.1186\/s43042-022-00260-6"},{"key":"3192_CR23","doi-asserted-by":"crossref","unstructured":"Farhadian P, Mokhtari MJ. Association between genetic variants (rs2839698, and rs217727) in lncRNA H19 and acute lymphoblastic leukemia susceptibility: a case-control study in the Iranian population [J]. Nucleosid Nucleotid Nucl Acids. 2024;1\u201315.","DOI":"10.1080\/15257770.2024.2422007"},{"key":"3192_CR24","doi-asserted-by":"crossref","unstructured":"Romeo M, Dallio M, Scognamiglio F et al. Role of non-coding RNAs in hepatocellular carcinoma progression: from classic to novel clinicopathogenetic implications [J]. Cancers. 2023;15(21).","DOI":"10.3390\/cancers15215178"},{"issue":"9","key":"3192_CR25","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1038\/s41418-022-00970-9","volume":"29","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Luo M, Cui X, et al. Long noncoding RNA NEAT1 promotes ferroptosis by modulating the miR-362-3p\/MIOX axis as a CeRNA [J]. Cell Death Differ. 2022;29(9):1850\u201363.","journal-title":"Cell Death Differ"},{"issue":"22","key":"3192_CR26","doi-asserted-by":"publisher","first-page":"22240","DOI":"10.1021\/acsnano.3c01199","volume":"17","author":"Y Gao","year":"2023","unstructured":"Gao Y, Tong M, Wong TL, et al. Long noncoding RNA URB1-Antisense RNA 1 (AS1) suppresses Sorafenib-Induced ferroptosis in hepatocellular carcinoma by driving ferritin phase separation [J]. ACS Nano. 2023;17(22):22240\u201358.","journal-title":"ACS Nano"},{"issue":"6","key":"3192_CR27","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1002\/hep.32079","volume":"74","author":"L Ma","year":"2021","unstructured":"Ma L, Xu A, Kang L, et al. LSD1-Demethylated LINC01134 confers oxaliplatin resistance through SP1-Induced p62 transcription in HCC [J]. Hepatology (Baltimore MD). 2021;74(6):3213\u201334.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"7483","key":"3192_CR28","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature12986","volume":"505","author":"Y Tay","year":"2014","unstructured":"Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of CeRNA crosstalk and competition [J]. Nature. 2014;505(7483):344\u201352.","journal-title":"Nature"},{"issue":"7","key":"3192_CR29","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/s41418-023-01183-4","volume":"30","author":"T Chen","year":"2023","unstructured":"Chen T, Meng Y, Zhou Z, et al. GAS5 protects against nonalcoholic fatty liver disease via miR-28a-5p\/MARCH7\/NLRP3 axis-mediated pyroptosis [J]. Cell Death Differ. 2023;30(7):1829\u201348.","journal-title":"Cell Death Differ"},{"issue":"1","key":"3192_CR30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41418-022-01049-1","volume":"30","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Shao Y, Hu W, et al. A novel long noncoding RNA SP100-AS1 induces radioresistance of colorectal cancer via sponging miR-622 and stabilizing ATG3 [J]. Cell Death Differ. 2023;30(1):111\u201324.","journal-title":"Cell Death Differ"},{"issue":"10","key":"3192_CR31","first-page":"11144","volume":"13","author":"N Zhou","year":"2021","unstructured":"Zhou N, Chen Y, Yang L, et al. LncRNA SNHG4 promotes malignant biological behaviors and immune escape of colorectal cancer cells by regulating the miR-144-3p\/MET axis [J]. Am J Translational Res. 2021;13(10):11144\u201361.","journal-title":"Am J Translational Res"},{"issue":"6","key":"3192_CR32","doi-asserted-by":"publisher","first-page":"e12515","DOI":"10.1111\/cpr.12515","volume":"51","author":"R Xu","year":"2018","unstructured":"Xu R, Feng F, Yu X, et al. LncRNA SNHG4 promotes tumour growth by sponging miR-224-3p and predicts poor survival and recurrence in human osteosarcoma [J]. Cell Prolif. 2018;51(6):e12515.","journal-title":"Cell Prolif"},{"key":"3192_CR33","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1186\/s12935-020-01606-z","volume":"20","author":"J Wu","year":"2020","unstructured":"Wu J, Liu T, Sun L, et al. Long noncoding RNA SNHG4 promotes renal cell carcinoma tumorigenesis and invasion by acting as CeRNA to sponge miR-204-5p and upregulate RUNX2 [J]. Cancer Cell Int. 2020;20:514.","journal-title":"Cancer Cell Int"},{"issue":"12","key":"3192_CR34","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.1016\/j.ymthe.2022.07.014","volume":"30","author":"J Pan","year":"2022","unstructured":"Pan J, Xie Y, Li H, et al. mmu-lncRNA 121686\/hsa-lncRNA 520657 induced by METTL3 drive the progression of AKI by targeting miR-328-5p\/HtrA3 signaling axis [J]. Mol Therapy: J Am Soc Gene Therapy. 2022;30(12):3694\u2013713.","journal-title":"Mol Therapy: J Am Soc Gene Therapy"},{"key":"3192_CR35","doi-asserted-by":"publisher","first-page":"653207","DOI":"10.3389\/fcell.2021.653207","volume":"9","author":"J Tu","year":"2021","unstructured":"Tu J, Chen W, Zheng L, et al. Circular RNA Circ0021205 promotes cholangiocarcinoma progression through MiR-204-5p\/RAB22A Axis [J]. Front Cell Dev Biology. 2021;9:653207.","journal-title":"Front Cell Dev Biology"},{"issue":"3","key":"3192_CR36","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1002\/jcp.29209","volume":"235","author":"J Tang","year":"2020","unstructured":"Tang J, Li Z, Zhu Q, et al. miR-204-5p regulates cell proliferation, invasion, and apoptosis by targeting IL-11 in esophageal squamous cell carcinoma [J]. J Cell Physiol. 2020;235(3):3043\u201355.","journal-title":"J Cell Physiol"},{"issue":"2","key":"3192_CR37","first-page":"212","volume":"23","author":"Y Liang","year":"2020","unstructured":"Liang Y, Zhang CD, Zhang C, et al. DLX6-AS1\/miR-204-5p\/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer [J]. Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc. 2020;23(2):212\u201327.","journal-title":"Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc"},{"issue":"18","key":"3192_CR38","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1038\/s41388-021-01671-2","volume":"40","author":"K Chen","year":"2021","unstructured":"Chen K, Hou Y, Liao R, et al. LncRNA SNHG6 promotes G1\/S-phase transition in hepatocellular carcinoma by impairing miR-204-5p-mediated Inhibition of E2F1 [J]. Oncogene. 2021;40(18):3217\u201330.","journal-title":"Oncogene"},{"key":"3192_CR39","doi-asserted-by":"crossref","unstructured":"Wang S, Zhu W, Qiu J et al. LncRNA SNHG4 promotes cell proliferation, migration, invasion and the epithelial-mesenchymal transition process via sponging miR-204-5p in gastric cancer [J]. Mol Med Rep. 2021;23(1).","DOI":"10.3892\/mmr.2020.11724"},{"issue":"6","key":"3192_CR40","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1093\/bib\/bbz142","volume":"21","author":"Q Dong","year":"2020","unstructured":"Dong Q, Li F, Xu Y, et al. RNAactDrug: a comprehensive database of RNAs associated with drug sensitivity from multi-omics data [J]. Brief Bioinform. 2020;21(6):2167\u201374.","journal-title":"Brief Bioinform"},{"issue":"6","key":"3192_CR41","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1002\/hep.31614","volume":"73","author":"MS Krishnan","year":"2021","unstructured":"Krishnan MS, Rajan KDA, Park J, et al. Genomic analysis of vascular invasion in HCC reveals molecular drivers and predictive biomarkers [J]. Hepatol (Baltim Md). 2021;73(6):2342\u201360.","journal-title":"Hepatol (Baltim Md)"},{"issue":"5","key":"3192_CR42","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death [J]. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"issue":"14","key":"3192_CR43","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications [J]. Cell. 2022;185(14):2401\u201321.","journal-title":"Cell"},{"issue":"12","key":"3192_CR44","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.tcb.2023.04.005","volume":"33","author":"AF Dos Santos","year":"2023","unstructured":"Dos Santos AF, Fazeli G, Xavier Da Silva TN, et al. Ferroptosis: mechanisms and implications for cancer development and therapy response [J]. Trends Cell Biol. 2023;33(12):1062\u201376.","journal-title":"Trends Cell Biol"},{"issue":"5","key":"3192_CR45","doi-asserted-by":"publisher","first-page":"771","DOI":"10.32604\/biocell.2024.048878","volume":"48","author":"CG Luo","year":"2024","unstructured":"Luo CG, Zhang J, An YZ, et al. MAPK9 as a therapeutic target: unveiling ferroptosis in localized prostate cancer progression [J]. Biocell. 2024;48(5):771\u201392.","journal-title":"Biocell"},{"issue":"3","key":"3192_CR46","doi-asserted-by":"publisher","first-page":"379","DOI":"10.32604\/biocell.2024.047812","volume":"48","author":"LS Ma","year":"2024","unstructured":"Ma LS, Shao WQ, Zhu WL. Exploring the molecular mechanisms and potential therapeutic strategies of ferroptosis in ovarian cancer [J]. Biocell. 2024;48(3):379\u201386.","journal-title":"Biocell"},{"key":"3192_CR47","doi-asserted-by":"crossref","unstructured":"Duan LL, Cao L, Liu JQ, et al. Identification of ferroptosis-Related prognostic models and FDFT1 as a potential ferroptosis driver in colorectal Cancer [J]. Curr Med Chem; 2025.","DOI":"10.2174\/0109298673377428250131112647"},{"issue":"5","key":"3192_CR48","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41419-021-03718-4","volume":"12","author":"Q Wang","year":"2021","unstructured":"Wang Q, Bin C, Xue Q, et al. GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via Inhibition of NRF2\/GPX4 axis [J]. Cell Death Dis. 2021;12(5):426.","journal-title":"Cell Death Dis"},{"issue":"8","key":"3192_CR49","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1016\/j.ymthe.2021.04.011","volume":"29","author":"W Song","year":"2021","unstructured":"Song W, Zheng C, Liu M, et al. TRERNA1 upregulation mediated by HBx promotes Sorafenib resistance and cell proliferation in HCC via targeting NRAS by sponging miR-22-3p [J]. Mol Therapy: J Am Soc Gene Therapy. 2021;29(8):2601\u201316.","journal-title":"Mol Therapy: J Am Soc Gene Therapy"},{"issue":"11","key":"3192_CR50","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/s41418-019-0304-y","volume":"26","author":"M Wang","year":"2019","unstructured":"Wang M, Mao C, Ouyang L, et al. Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA [J]. Cell Death Differ. 2019;26(11):2329\u201343.","journal-title":"Cell Death Differ"},{"key":"3192_CR51","doi-asserted-by":"crossref","unstructured":"Chen P, Dong Z, Zhu W, et al. Noncanonical regulation of HOIL-1 on cancer stemness and Sorafenib resistance identifies pixantrone as a novel therapeutic agent for hepatocellular carcinoma [J]. Hepatology (Baltimore, Md); 2023.","DOI":"10.1097\/HEP.0000000000000623"},{"issue":"4","key":"3192_CR52","doi-asserted-by":"publisher","first-page":"e337","DOI":"10.1002\/mco2.337","volume":"4","author":"B Yan","year":"2023","unstructured":"Yan B, Guo J, Wang Z, et al. The ubiquitin-specific protease 5 mediated deubiquitination of LSH links metabolic regulation of ferroptosis to hepatocellular carcinoma progression [J]. MedComm. 2023;4(4):e337.","journal-title":"MedComm"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03192-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03192-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03192-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T13:56:37Z","timestamp":1757253397000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03192-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3192"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03192-w","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"22 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been updated to correct the affiliations.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Animal experiments were approved by the Institutional Animal Care and Use Committee of the second Xiangya hospital of the Central South University, and performed in accordance with the Guide for the Care and Use of Laboratory Animals. Informed consent was obtained from all HCC patients who provided tissues. This study was approved by Zhuzhou Central Hospital Ethics Committee before the study began (ZZCHEC2022089-01), and was conducted in compliance with the guidelines of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"1349"}}